---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-085853"
form_type: "8-K"
ticker: "SXTP"
cik: "0001946563"
company_name: "60 DEGREES PHARMACEUTICALS, INC."
filed_at: "2025-09-09T23:59:59+00:00"
generated_at: "2026-05-17T07:22:46.965618+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# 60 Degrees Pharmaceuticals presents at H.C. Wainwright; no specific updates disclosed in filing

## Summary
- CEO Geoff Dow scheduled to present to investors starting September 9, 2025.
- Slide deck furnished to investors; filing text does not contain its substantive content.
- No financial figures, guidance, or pipeline milestones provided in the 8-K.
- Company is an emerging growth company listed on Nasdaq under SXTP and SXTPW.

## SEC filing metadata
- accession: 0001213900-25-085853
- form_type: 8-K
- ticker: SXTP
- cik: 0001946563
- company_name: 60 DEGREES PHARMACEUTICALS, INC.
- filed_at: 2025-09-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1946563/000121390025085853/0001213900-25-085853-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1946563/000121390025085853/ea0256483-8k_60degrees.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-085853
- JSON: https://secwatch.observer/filing/0001213900-25-085853.json
- Plain text: https://secwatch.observer/filing/0001213900-25-085853.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.